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Abstract
Background: Chanarin Dorfman Syndrome (CDS) is a rare autosomal recessive disorder characterized by ichthyosiform
non-bullous erythroderma and variable involvement of the liver and the neuromuscular system. In CDS patients, the
accumulation of neutral lipids inside cytoplasmic lipid droplets has been demonstrated in different tissues. To date,
ninety families with this disease have been described worldwide; most of them are from Mediterranean countries.
Case presentation: In this report, we describe a consanguineous Turkish family with typical features of CDS. The
parents are first cousins and are both diseased. At the age of eight, their child presented CDS with non-bullous
congenital ichthyosiform erythroderma, hepatosteatosis, hepatomegaly and ectropion. Electromyographic
examination is compatible with myopathy. A five-year-old cousin of the child is also affected by CDS. She was
born to non-affected consanguineous parents. Mutation analysis of the ABHD5 gene revealed the previously
reported mutation, N209X, which is the most frequent in Turkish patients. Lipid vacuoles, also known as Jordan’s
anomaly, are detectable in their leucocytes.
Conclusions: To the best of our knowledge, this is the first report of a CDS family in which both parents and
their child are affected by CDS. To date, the child does not present a more severe clinical phenotype compared
with those of his relatives or other CDS patients of the same age. These findings suggest that high levels of
triacylglycerol accumulation, that may be supposed to be present in high amount inside the ooplasm, did not
affect embryo development and foetal growth.
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Background
Neutral lipid storage disease with ichthyosis, which is also
known as Chanarin Dorfman Syndrome (CDS; MIM
275630), is a rare autosomal recessive disease characterized
by the intracellular accumulation of triacylglycerol (TG) in
numerous tissues [1, 2]. The clinical phenotype involves
multiple organs and systems, including skin, liver, skeletal
muscle, eyes, ears, and the central nervous system. How-
ever, in this syndrome, the degree of systemic involvement
is quite variable [2–5]. ABHD5 (α/β hydrolase domain 5), a
cofactor for adipose triglyceride lipase (ATGL), has been
identified as a causative gene of CDS [6]. Indeed, different
ABHD5 mutations determine the partial or total loss of
ATGL activation, leading to the accumulation of TG inside
lipid droplets [2–5]. Lipid droplets are highly dynamic and
ubiquitous cellular organelles. These droplets are a funda-
mental component of lipid homeostasis, i.e., a universal
feature of eukaryotic cells that can ensure a rapidly mobi-
lized lipid source for numerous biochemical processes [7].
Neutral lipids also accumulate in oocytes and blastomeres
as lipid droplets, providing energy for mammalian embryo
preimplantation, proper growth and development [8].
In the peripheral leukocytes of CDS patients, neutral
lipids inside lipid droplets are easily detectable with
standard or specific stains, and they are known as Jordan’s
anomalies, the most common laboratory findings of the
disease [9].
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One hundred and twenty-eight CDS patients have
been reported worldwide (Additional file 1: Table S1).
For 85 of these patients, clinical diagnosis has been con-
firmed by ABHD5 mutation analysis. The highest num-
ber of CDS patients (27 cases) has been described in
Turkey, mainly due to the high incidence of consanguin-
eous marriages [10]. Nevertheless, the clinical and genetic
description of families in which both parents and children
are affected by CDS has never been reported before.
Case presentation
Here, we present a CDS Turkish family with four affected
members (Fig. 1a, III-1, III-2, IV-1, IV-2). The child (IV-1)
was an 8-year-old male born at 38 weeks of gestation and
weighing 3400 g. He presented lamellar ichthyosis at birth.
At first examination (at the age of 5), he had lagophthal-
mos and ectropion. Ophthalmologists did not record
lagophthalmos in subsequent examinations, so the condi-
tion was considered a compliance problem. He had ele-
vated transaminase (ALT: 75 U/L; normal 5-35 U/L; GGT
31 U/L; normal 5-17 U/L), creatine phosphokinase (CK:
1677 U/L; normal 22-200 U/L), triglyceride (460 mg/dl;
normal 35-130 mg/dl), and total cholesterol levels
(135 mg/dl; normal 110-200 mg/dl) (Table 1). Systemic
examination revealed 2 cm hepatomegaly. Abdominal
ultrasonography was compatible with hepatosteatosis and
hepatomegaly. Electromyographic examination revealed
signs of myopathy.
His parents (both 44 years old) were paternal cousins. Both
presented lamellar ichthyosis, ectropion, hypertriglyceridemia,
Fig. 1 Pedigree of CDS family (a). Microphotographs of May-Grünwald-Giemsa buffy coats of patient III-1 showing Jordan’s anomaly (arrows);
original magnification 1000× (b). Sequence analysis showing the c594insC (N209X) ABHD5 mutation identified in homozygous status in all family
members affected by CDS (c)
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hepatomegaly and hepatosteatosis (Table 1). In both
parents and the child, dermatological examination re-
vealed widespread ichthyosis on the facial region, trunk,
extensor and flexural regions and scalp. The individual
scales over the trunk were white, fine, translucent and
semi-adherent, whereas those on the limbs and face
were grey-brown, larger in size, polygonal and adherent
(Fig. 2). No bullous lesions or erosions were noted. The
involvement of palms and soles, dental anomaly and
nail dystrophy was absent.
In the 5-year-old girl (IV-2), ichthyosis was also
present in flexural regions (Fig. 2). Corrugated appear-
ance and hyperpigmented scales were detected on foot,
back, knee, and elbow. Laboratory investigation revealed
increased ALT (86 U/L) (alanine transaminase), AST
(aspartate transaminase) (88 U/L) and CK (1145 U/L)
levels (Table 1). Electromyographic examination revealed
myopathy. Abdominal ultrasonography revealed hepa-
tosteatosis causing hepatomegaly. Ophthalmological and
audiological examinations were normal.
A peripheral blood smear stained with May-Grünwald-
Giemsa revealed lipid vacuoles (Jordan’s anomaly) in leuco-
cytes from all patients (Fig. 1b). After obtaining informed
consent and in accordance with the Declaration of Helsinki
principles, the coding regions of the ABHD5 gene were se-
quenced, and a homozygous N209X mutation was identi-
fied (Fig. 1c). For molecular analysis, oligonucleotides
were selected to amplify and sequence the seven exons
of ABHD5, their intron/exon boundaries, and the can-
didate promoter regions. The primer sequences and the
amplification conditions were previously reported [2].
A few days after molecular diagnosis, the father died of
a heart attack at the age of 44. He had no prior cardiac
history. However, PNPLA2 gene analysis was performed,
excluding disease-causing mutations.
The CARE guidelines were followed in this case.
Discussion and conclusions
The N209X mutation identified in our CDS family is the
most common in the Turkish CDS population. Nur et al.
compared clinical findings between patients carrying this
mutation with other ABHD5 variations and noted no
significant differences [10]. In CDS patients, skin involve-
ment is prevalent and a consistently observed clinical fea-
ture, consisting of a non-bullous congenital ichthyosiform
erythroderma. Sano et al. demonstrated that the severity
of ichthyosis positively correlates with TG level in the
scales from patients [11]. In our affected subjects, a wide-
spread lamellar ichthyosis detected since birth revealed a
homogeneous CDS phenotype. Notably, skin involvement
did not appear more severe in the child; however, it is pos-
sible to hypothesize increased accumulation of TG in
ectodermal cells during embryonic development. Liver ab-
normalities can occur in greater than 80% of patients, ran-
ging from hepatomegaly or liver steatosis to cirrhosis, and
can be observed in young children, as occurred in this
family [4, 6]. Neurological impairment was not detected
in our patients; however, intellectual disability has been
reported in 20% of CDS subjects and in approximately
40% of those carrying the N209X mutation [10–12].
Table 1 Clinical and laboratory features of patients with Chanarin-Dorfman syndrome
Clinical feature Child Father Mother Cousin
Ichthyosis + + + +
Leukocyte vacuoles + + + +
Creatinine phosphokinase levels (U/L) 1677 290 219 1145
Electromyographic examination Myopathy Normal Normal Myopathy
Triglyceride level (mg/dL) 460 115 74 74
Total cholesterol level (mg/dL) 135 151 115 140
Cataracts – – – –
Ectropion + + + –
Lagophthalmos + – – –
Strabism – – – –
Myopia – + – –
Hearing loss – – – –
Mental retardation – – – –
Hepatomegaly + (2 cm) + + + (2 cm)
Hepatosteatosis + + + +
Microcephaly – – – –
Intestinal involvement – – – –
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Sensorineural hearing loss was not present in our
family; however, this condition occurs in 30% of CDS
patients. Muscle involvement was evident only in the
two children. Clinically, the children did not exhibit
significant muscle weakness, fatigue or exercise intoler-
ance. However, an electromyographic examination (EMG)
was performed because of an elevation in CK levels and
revealed a myopathic pattern. In CDS, muscle abnormali-
ties have been detected in 40% of subjects. Myopathy
typically begins in the thirties, but it has also been
described in very young children [2, 13].
In conclusion, we describe a family in which all mem-
bers are affected by CDS. When the child was born, his
mother was 36 years old. She did not indicate any infer-
tility problems or history of abortion. This paper de-
scribes the unique reported case of natural conception
and pregnancy between two CDS patients. No particular
pregnancy complications were observed. Therefore, the
storage of neutral lipids inside lipid droplets did not dra-
matically increase during oocyte maturation. Indeed,
embryo development and foetal growth were not af-
fected. To date, the child does not present new symp-
toms or an exacerbation of the clinical phenotype even
with regard to dermatologic manifestations compared
with the symptoms and phenotypes of his relatives or
other CDS patients. Instead, a relevant aspect for these
three patients seems to be represented by the psycho-
genic stress due to isolation from society, colleagues,
school friends and relatives. Finally, after molecular diag-
nosis, the two children immediately started a special
diet, poor in fatty acids with medium chain triglycer-
ides (MCT), as hepatic and dermatologic improve-
ment has been reported in different cases consuming
such a diet.
Fig. 2 Dermatological characterization of CDS patients. Lamellar ichthyosis affecting facial region (a, d, e, g), trunk (b, c, f, h), and extremities (i) of
child (patient IV-1; a, b, c), father (patient III-2; d), mother (patient III-1; e, f) and cousin (patient IV-2; g, h, i). Prominent eyelid ectropion in father
(d) and mother (e)
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literature. (DOCX 30 kb)
Abbreviations
ABHD5: α/β-hydrolase domain-containing protein 5; ALT: Alanine
aminotransferase test; AST: Aspartate aminotransferase test; ATGL: Adipose
triglyceride lipase; CDS: Chanarin-Dorfman syndrome; CK: Creatine kinase;
GGT: Gamma glutamyl transpeptidase; LD: Lipid droplet; MCT: Medium chain
triglycerides; NCIE: Non-bullous congenital ichthyosiform erythroderma;
NLSDI: Neutral lipid storage disease with ichthyosis; TG: Triacylglicerol
Acknowledgements
The authors are grateful to the patients for their kind cooperation.
Funding
Università Cattolica del Sacro Cuore (Milan, Italy) sustained the publication of
this article.
Availability of data and materials
Data obtained during this study are included in the article and its additional files.
Authors’ contributions
MD performed the clinical characterization of patients and he is taking care
of them; SM performed the molecular analysis and critically revised the
manuscript; LM supervised the study and critically revised the manuscript;
DT conceived the study, supervised it and wrote the manuscript. All authors
read and approved the final manuscript.
Ethics approval and consent to participate
Informed consent for genetic analysis was obtained from the study participants.
This manuscript reports the description of a family who presented with CDS
clinical symptoms. No experiments were performed and no hypothesis were
tested for this study. This case report does not constitute systematic research,
therefore no ethics approval was necessary.
Consent for publication
Written informed consent was obtained from adult patients and the guardians of
two young patients for publication of this Case report and any accompanying
images. A copy of the written consent is available for review by the Editor of this
journal.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Baskent University Faculty of Medicine, Department of Dermatology, Adana
Hospital, Adana, Turkey. 2Laboratory of Cellular Biochemistry and Molecular
Biology-CRIBENS, Catholic University of the Sacred Heart, pz Buonarroti 30,
20145 Milan, Italy. 3Department of Psychology, Catholic University of the
Sacred Heart, Largo Gemelli 1, 20123 Milan, Italy. 4Department of
Pharmaceutical Sciences, University of Piemonte Orientale, Lgo Donegani 2,
28100 Novara, Italy.
Received: 19 February 2018 Accepted: 18 May 2018
References
1. Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R. Neutral lipid
storage disease: genetic disorders caused by mutations in adipose triglyceride
lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab. 2009;297:
289–96.
2. Redaelli C, Coleman RA, Moro L, Dacou-Voutetakis C, Elsayed SM, Prati D,
Colli A, Mela D, Colombo R, Tavian D. Clinical and genetic characterization
of chanarin-dorfman syndrome patients: first report of large deletions in the
ABHD5 gene. Orphanet J Rare Dis. 2010;5:33.
3. Bruno C, Bertini E, Di Rocco M, Cassandrini D, Ruffa G, De Toni T, et al.
Clinical and genetic characterization of Chanarin-Dorfman syndrome.
Biochem Biophys Res Com. 2008;369:1125–8.
4. Missaglia S, Valadared ER, Moro L, Faguntes ED, Quintão Roque R, Giardina
B, et al. Early onset of Chanarin-Dorfman syndrome with severe liver
involvement in a patient with a complex rearrangement of ABHD5
promoter. BMC Med Genet. 2014;15:32.
5. Takeichi T, Sugiura K, Tso S, Simpson MA, McGrath JA, Akiyama M. Bi-allelic
nonsense mutations in ABHD5 underlie a mild phenotype of Dorfman-
Chanarin syndrome. J Dermatol Sci. 2016;81:134–6.
6. Lefevre C, Jobard F, Caux F, Bouadjar B, Karaduman A, Heilig R, et al.
Mutations in CGI-58, the gene encoding a new protein of the esterase/
lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum
Genet. 2001;69:1002–12.
7. Welte MA. Expanding roles for lipid droplets. Curr Biol. 2015; https://doi.org/
10.1016/j.cub.2015.04.004.
8. Prates EG, Nunes JT, Pereira RM. A role of lipid metabolism during cumulus-
oocyte complex maturation: impact of lipid modulators to improve embryo
production. Mediat Inflamm. 2014; https://doi.org/10.1155/2014/692067.
9. Tavian D, Colombo R. Improved cytochemical method for detecting Jordans’
bodies in neutral-lipid storage diseases. J Clin Pathol. 2007;60:956–8.
10. Nur BG, Gencpinar P, Yuzbasioglu A, Emre SD, Mihci E. Chanarin Dorfman
syndrome: genotype-phenotype correlation. Eur J Med Genet. 2015;58:238–42.
11. Ujihara M, Nakajima K, Yamamoto M, Teraishi M, Uchida Y, Akiyama M, et al.
Epidermal triglyceride levels are correlated with severity of ichthyosis in
Dorfman-Chanarin syndrome. J Dermatol Sci. 2010;57:102–7.
12. Pennisi EM, Arca M, Bertini E, Bruno C, Cassandrini D. D'amico a et al.
clinical/genetic features and natural history in a large cohort of Italian
patients. Orphanet J Rare Dis. 2017;12:90.
13. Gupta N, Gothwal S, Satpathy AK, Missaglia S, Tavian D, Das P, et al.
Chanarin Dorfman syndrome. A case report with novel nonsense mutation.
Gene. 2016;10:359–62.
Durdu et al. BMC Medical Genetics  (2018) 19:88 Page 5 of 5
